Contineum therapeutics to attend the 7th annual evercore healthconx conference

San diego--(business wire)--contineum therapeutics, inc. (nasdaq: ctnm) (contineum or the company), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments in the treatment of neuroscience, inflammation and immunology (ni&i) indications, today announced that management is scheduled to participate in a fireside chat at the 7th annual evercore healthconx.
EVR Ratings Summary
EVR Quant Ranking